Abstract
ObjectivesWe evaluated retention rate and discontinuation due to efficacy and safety of Adalimumab (ADA) in Japanese patients with rheumatoid arthritis (RA) in daily practice.MethodsAll RA patients (n=476) who underwent ADA...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
